Skip to main content
padlock icon - secure page this page is secure

Drug-Loaded Magnetic Microhydrogel as Microwave Susceptible Agents for Cancer Multimodality Treatment and MR Imaging

Buy Article:

$106.34 + tax (Refund Policy)

Microwave (MW) ablation has been widely recognized as one of prominent protocols for clinical cancer treatment with advantages of minimally invasive treatment, convenient operation and consistent intra-tumoral temperature. However, microwave therapeutic approach still has the risk of overheating the surrounding healthy tissues, which thus necessitates susceptible agent to concentrate the heat and enhance the treatment efficiency with lower microwave power while avoiding side effects. Herein, a doxorubicin (DOX)-loaded magnetic nanocomposite calcium alginate microhydrogel (Fe3O4@DOX/CAM) as microwave susceptible and MR contrast agent has been developed for in vivo tumor multimodality therapy. Membrane emulsification method was employed for the fabrication of the monodispersed microhydrogel with rather uniform size distribution. Even under microwave irradiation at extremely low microwave power (2 W), enough heat (∼50 °C) can be induced by the microhydrogel. Except for as an excellent susceptible agent for microwave thermotherapy, the as-prepared Fe3O4@DOX/CAM can achieve microwave responsive DOX delivery, as it was noticed that microwave heating can actually facilitate drug release. Moreover, such multifunctional Fe3O4@DOX/CAM can be administered by intra-tumoral injection to achieve MW thermotherapy combined with sustainable chemotherapy. Meanwhile, the magnetic nanoparticles incorporated within the microhydrogel can be applied for T2-weighted MR image during the cancer treatment. In summary, our observations on such Fe3O4@DOX/CAM suggest an effective microwave susceptible agent for cancer multimodality treatment and imaging.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics


Document Type: Research Article

Publication date: February 1, 2018

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more